Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 644 results for "clopidogrel"

Human medicines European public assessment report (EPAR): Cl...

This is a summary of the European public assessment report (EPAR) for Clopidogrel ratiopharm. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide ... European Medicines Agency, 2 weeks ago

3 images for "clopidogrel"

TCTMD.com, 1 month ago
MDLinx, 2 months ago
MDLinx, 2 months ago
Tech Times

Clopidogrel With PPIs: No Increased Risk of Stroke

Reuters Health Information By David Douglas February20,2015 NEW YORK (Reuters Health) - Users of clopidogrel and concomitant proton pump inhibitors (PPIs) are not at increased risk of ischemic stroke, according to researchers. "To exert its ...
 Diabetes Care1 month ago Aspirin resistance tied to more severe strokes  UnitedHealthcare2 weeks ago Resistance To Aspirin May Point To Increased Risks Of Severe Stroke  Tech Times1 month ago Study, Aspirin Resistance Is a Precursor to Stroke  NewsHub South Africa1 month ago
[x]  

Cholesterol and death certificates: Doctor Rosemary Leonard answers your medical queries

GETTING to the heart of medical matters Q I take clopidogrel and atorvastatin following a mini stroke. I now bruise easily and have very low cholesterol. With thinner blood is there more of a risk of a brain aneurysm-While lower cholesterol is ...
 Scottish Daily Express1 month ago

Market Research Report on Global and Chinese Clopidogrel bisulfate Industry, 2009-2019

is a professional and in-depth market survey on Global and Chinese Clopidogrel bisulfate industry. The report firstly reviews the basic information of Clopidogrel bisulfate including its classification, application and manufacturing technology; The ...
 Individual.com1 month ago

Clopidogrel-PPI Interaction Questioned in Meta-analysis

DURHAM, NC — There is a disconnect between results derived from observational studies examining the safety of using proton-pump inhibitors (PPIs) with dual antiplatelet therapy and the results obtained from randomized, controlled clinical ...
 Dermatology Online Journal1 month ago

Post-Hoc Analyses of TRA-2°P Trial Show Efficacy of Zontivity with Aspirin and Clopidogrel

— Merck announced results from two post-hoc analyses of the TRA 2°P TIMI 50 (Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) trial of Zontivity (vorapaxar), one of the largest secondary prevention studies ...
 Diagnostic & Invasive Cardiology3 weeks ago Two New Post-Hoc Analyses of TRA 2°P TIMI 50 Study Showed ZONTIVITY® (vorapaxar) Added to Aspirin and/or Clopidogrel Reduced Acute Limb Ischemia and Peripheral Revascularizations, Respectively, in Certain Patients with Peripheral Arterial Disease  TMC Net3 weeks ago Merck : Two New Post-Hoc Analyses of TRA 2°P TIMI 50 Study Showed ZONTIVITY® (vorapaxar) Added to Aspirin and/or Clopidogrel Reduced Acute Limb Ischemia and Peripheral Revascularizations, Respectively, in Certain Patients with Peripheral Arterial Disease  4 Traders3 weeks ago Vorapaxar may reduce acute limb ischemia, peripheral revascularization in patients with PAD  Orthopedics Today5 days ago
[x]  

NICE recommends Xarelto (rivaroxaban) as an effective treatment option for reducing risk of secondary events in ACS

NICE FAD recommends 2.5mg Xarelto twice daily in combination with aspirin alone or aspirin plus clopidogrel or ticlopidine, as an option for secondary prevention following ACS in patients with elevated cardiac biomarkers, without prior stroke or ...
 FirstWord Pharma2 months ago NICE Recommends Xarelto®▼ (rivaroxaban) as an Effective Treatment Option for Reducing Risk of Secondary …  Yahoo! Finance2 months ago NICE Recommends Xarelto(R)a- 1/4 (rivaroxaban) as an Effective Treatment Option for Reducing Risk of Secondary Events in ACS[1]  Individual.com2 months ago
[x]  
Pharmafocus

NICE recommends rivaroxaban (Xarelto) to prevent blood clots in people who have had a heart attack

In final guidance published today NICE has recommended rivaroxaban (Xarelto, Bayer Healthcare), in combination with clopidogrel and aspirin, or with aspirin alone, as an option for preventing blood clots in people who have had an acute coronary ...
 NICE4 days ago NICE decisions made on Bayer, Celgene and Boehringer drugs  Pharmafocus3 days ago NICE recommends Bayer heart attack drug  Pharmafocus2 months ago
[x]  

Clopidogrel Resistance After Renal Transplantation

1 , BARBARA SANDOR 2 , KAROLY KALMAR NAGY 1 , DORA PRAKSCH 2 , KATALIN GOMBOS 3 , ANDRAS TOTH 2 , KALMAN TOTH 2 and PETER SZAKALY 1 ⇑ 1 Department of Surgery, University of Pecs, School of Medicine, Pecs, Hungary 2 First Department of ...
 In Vivo1 week ago

NOVEL HIGH-POTENCY ORAL ANTIPLATELET DRUGS VERSUS CLOPIDOGREL IN PATIENTS UNDERGOING COMPLEX PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM A LARGE SINGLE-CENTER ALL-COMERS REGISTRY

Note: Since your browser does not support Javascript, you must press the Continue button once
 Journal of the American College of Cardiology1 week ago CHINESE PEOPLE : New Findings from Chinese People's Liberation Army Update Understanding of Percutaneous Coronary Intervention (Effect of high-dose clopidogrel...  4 Traders1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - clopidogrel
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less